In high-grade gliomas the activity of Bcl-2 family members is usually deregulated; in particular, these tumors display increased expression of the anti-apoptotic factors Bcl-2, Bcl-xL, and Mcl-1, and decreased expression levels of the pro-apoptotic protein Bax37. This evidence concerns the gene BCL2L1 and central nervous system cancer.